Allspring Global Investments
TNYA icon

Allspring Global Investments’s Tenaya Therapeutics TNYA Stock Holding History

Allspring Global Investments’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,406
Closed -$181K – 2931
2022
Q1 		$181K Sell
15,406
-1,848
-11% -$22.4K ﹤0.01% 2600
2021
Q4 		$326K Buy
+17,254
New +$376K ﹤0.01% 2470

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Allspring Global Investments's TNYA Position: Q2 2022 in Review

Allspring Global Investments sold out of Tenaya Therapeutics (TNYA) in Q2 2022, closing a stake of 15,406 shares — an estimated $181K sold.

Allspring Global Investments first reported a position in TNYA in Q4 2021 and held it in 2 quarters. The position peaked at $326K in Q4 2021. 50 funds tracked by Wall St. Rank hold TNYA as of Q2 2022.

  • Allspring Global Investments reported no remaining Tenaya Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 15,406 Tenaya Therapeutics shares in Q2 2022, an estimated $181K.
  • Allspring Global Investments first reported a position in Tenaya Therapeutics in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Tenaya Therapeutics position peaked at $326K in Q4 2021.
  • 50 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.